Nicholas Donoghoe
Vermogen: 19 M $ op 30-09-2026
Vermogen: 19 M $ op 30-09-2026
Nicholas J.
Donoghoe is currently Executive VP, Chief Business & Strategy Officer at AbbVie, Inc., a position held since 2019.
Formerly, Dr. Donoghoe was a Partner at McKinsey & Co., Inc. Dr. Donoghoe earned a doctorate from The Johns Hopkins University School of Medicine.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 14-08-2026 | 74.430 ( 0% ) | 19 M $ | 30-09-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ABBVIE INC. | Corporate Officer/Principal | 01-01-2019 |
| Bedrijven | Functie | Einde |
|---|---|---|
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
AbbVie, Inc.
AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
The Johns Hopkins University School of Medicine
The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau